Optovue

Optovue
Name	Optovue
Type	Private
Industry	Medical devices
Founded	2002
Headquarters	Fremont, California
Key people	Joel Shekhter
Products	Optical coherence tomography devices

Optovue is a medical technology company specializing in optical coherence tomography (OCT) systems for ophthalmology and optometry, with devices used in clinical diagnosis, research, and surgical planning. The company develops imaging platforms integrating hardware and software for retinal, glaucoma, anterior segment, and corneal assessment. Optovue's products are distributed globally and are referenced in publications, clinical trials, and regulatory filings.

History

Founded in 2002 in Fremont, California, the company emerged during a period of rapid development in biomedical optics and photonics, alongside institutions and companies such as Massachusetts Institute of Technology, Stanford University, University of California, Berkeley, National Institutes of Health, American Academy of Ophthalmology, and Association for Research in Vision and Ophthalmology. Early milestones involved collaborations and technology migration from academic groups including researchers associated with Harvard University, University of California, San Diego, and University of Pennsylvania. The firm expanded its global footprint through partnerships and distribution agreements with organizations in Japan, Germany, United Kingdom, China, and India, aligning with international standards set by bodies like Food and Drug Administration and International Organization for Standardization. Growth phases included product launches, participation at conferences such as American Society of Cataract and Refractive Surgery and European Society of Cataract and Refractive Surgeons, and strategic hires from companies such as Carl Zeiss Meditec, Topcon, Nidek, Heidelberg Engineering, and Alcon.

Products and Technology

The product portfolio centers on spectral-domain OCT and swept-source OCT platforms and ancillary modules for angiography, anterior segment imaging, and corneal topography, developed using optical engineering principles from groups at Optical Society of America, IEEE Photonics Society, and SPIE. Key system components relate to interferometry methods explored in laboratories at Bell Labs, Rutherford Appleton Laboratory, and MIT Lincoln Laboratory. Software features include segmentation algorithms, three-dimensional reconstruction, and quantitative metrics inspired by techniques from National Institute of Standards and Technology, machine learning research at Carnegie Mellon University, and image analysis methods used at Johns Hopkins University. Devices are positioned against competing platforms from Heidelberg Engineering, Zeiss, Topcon, Nidek, Canon Medical Systems, and Carl Zeiss Meditec. The company has released modules for optical coherence tomography angiography, pachymetry, and anterior chamber analysis, incorporating sensors and optics comparable to technologies seen in Intel Corporation research and photonics innovations from Sony and Hamamatsu Photonics.

Clinical Applications

Clinical uses include diagnosis and management of retinal diseases such as age-related macular degeneration and diabetic retinopathy, linking to clinical trial frameworks at National Eye Institute, Moorfields Eye Hospital, Bascom Palmer Eye Institute, and Wills Eye Hospital. Systems support glaucoma evaluation through optic nerve head analysis, nerve fiber layer assessment, and intraocular pressure adjunct studies often conducted with collaborators like Massachusetts Eye and Ear, Bascom Palmer, and Kellogg Eye Center. Anterior segment applications assist in cataract and refractive surgery planning with references to outcomes reported at Cleveland Clinic, Mayo Clinic, and Johns Hopkins Hospital. Multicenter studies involving institutions such as University College London, Singapore National Eye Centre, and Sheikh Khalifa Medical City have included OCT-derived endpoints. Devices are used in educational programs at Case Western Reserve University School of Medicine and Columbia University Vagelos College of Physicians and Surgeons.

Regulatory Approvals and Standards

Regulatory clearances and conformity involve approvals and certifications linked to agencies and standards bodies including the Food and Drug Administration, European Medicines Agency, Medicines and Healthcare products Regulatory Agency, and International Electrotechnical Commission. Compliance aligns with ISO standards such as those issued by International Organization for Standardization and test protocols referenced by Underwriters Laboratories and Clinical Laboratory Improvement Amendments frameworks when applicable. Market entry strategies have engaged notified bodies in Netherlands, Germany, and Switzerland and have tracked guidance from World Health Organization and regional health authorities in Australia and Canada.

Research and Publications

Optovue systems are cited in peer-reviewed journals and conference proceedings from venues including Investigative Ophthalmology & Visual Science, Ophthalmology, The Lancet, British Journal of Ophthalmology, Nature Medicine, Science Translational Medicine, and proceedings of ARVO and AAO meetings. Collaborations with research centers such as Scripps Research, Fred Hutchinson Cancer Research Center, Dana–Farber Cancer Institute, and Broad Institute have contributed to studies on OCT biomarkers, computational imaging, and OCT angiography. Published work spans clinical trials registered with ClinicalTrials.gov, retrospective cohort studies from Johns Hopkins University, population studies associated with Framingham Heart Study methods, and technology assessments appearing in IEEE Transactions on Medical Imaging.

Corporate Structure and Ownership

The company operates as a privately held entity with executive leadership drawn from medical device, optics, and healthcare management sectors, comparable to leadership profiles seen at Medtronic, Stryker Corporation, Boston Scientific, Bausch + Lomb, and Johnson & Johnson Vision. Corporate functions include research and development, quality systems, regulatory affairs, and global sales channels, interfacing with distributors and partners in markets served by GE Healthcare, Siemens Healthineers, and Philips Healthcare. Strategic investments and partnerships mirror practices from venture-backed medtech firms and collaborations with academic technology transfer offices at Stanford Technology Ventures Program and MIT Technology Licensing Office.

Awards and Recognition

The company and its products have been featured at industry exhibitions and received recognition in contexts similar to awards from Medical Design Excellence Awards, Red Dot Design Award, Frost & Sullivan, and exhibitor honors at RSNA, AAO Annual Meeting, and EURETINA. Validation studies and clinician endorsements have been presented at institutions including Bascom Palmer Eye Institute, Moorfields Eye Hospital, and Massachusetts Eye and Ear.

Category:Medical device companies of the United States